PGC-1α mRNA increased in 21 out of 27 tumours expressing detectable levels at baseline, but the observed change in the total patient group was not statistical significant (Figure 1B; mean change of 1.91; P=0.032). This evidence concerns the gene PPARGC1A and neoplasm.